Cargando…

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer

Detalles Bibliográficos
Autores principales:	Tang, Hui, Liu, Wei, Huang, Kaiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977156/ https://www.ncbi.nlm.nih.gov/pubmed/35178871 http://dx.doi.org/10.1111/1759-7714.14355

Ejemplares similares

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
por: Eriguchi, Takahisa, et al.
Publicado: (2016)

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
por: Li, Ming, et al.
Publicado: (2017)

Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population‐based study
por: Ge, Yizhi, et al.
Publicado: (2020)

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
por: Ho, Chin-Beng, et al.
Publicado: (2023)

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2023)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Surgery for patients with cTis N0 M0 non–small cell lung cancer: It's time to say less is more
por: Li, Ming, et al.
Publicado: (2023)

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
por: Holmes, Oliver Edwin, et al.
Publicado: (2017)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
por: Narita, Atsuya, et al.
Publicado: (2019)

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
por: Nemoto, Takafumi, et al.
Publicado: (2022)

Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy
por: Kennedy, William R., et al.
Publicado: (2019)

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
por: Monjazeb, Arta M., et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience
por: Hobbs, Corey J., et al.
Publicado: (2017)

Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2023)

Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis
por: Dong, Baiqiang, et al.
Publicado: (2020)

Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study
por: Nakagawa, Keiichi, et al.
Publicado: (2014)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
por: Hijazi, Hussam, et al.
Publicado: (2016)

Stereotactic body radiation therapy using CyberKnife for T1N0M0 lung cancer patients with severe pulmonary dysfunction
por: Abe, Takanori, et al.
Publicado: (2020)

Safety and efficacy of ultrasound-guided thermal ablation in treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: A meta-analysis
por: Wang, Mei-Huan, et al.
Publicado: (2022)

Stereotactic radiosurgery alone for small cell lung cancer: a neurocognitive benefit?
por: Ojerholm, Eric, et al.
Publicado: (2014)

A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy
por: Zhao, Genghao, et al.
Publicado: (2022)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic
por: Aitken, K., et al.
Publicado: (2020)

Stereotactic ablative body radiotherapy for oligometastatic inguinal lymph node in castrate resistant prostate cancer
por: Goyal, Shikha, et al.
Publicado: (2023)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Comment on: “Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis”
por: Liu, Xiangyu, et al.
Publicado: (2022)

Solid component proportion is an important predictor of tumor invasiveness in clinical stage T(1)N(0)M(0) (cT(1)N(0)M(0)) lung adenocarcinoma
por: Li, Meng, et al.
Publicado: (2018)

Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
por: Liu, Lei, et al.
Publicado: (2021)

Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
por: Li, Chunyan, et al.
Publicado: (2021)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015)

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study
por: Guo, Yanling, et al.
Publicado: (2023)

A comparison of epidural infusion of 0.2, 0.25, and 0.3% ropivacaine with fentanyl after unilateral total knee arthroplasty
por: Lee, Jae Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eth7i6kpms86g976nqov80a55s